February 8, 2023 01:22 PM EST
Pharma
Manufacturing

As­traZeneca moves for­ward with a $360M API plant in Ire­land

Tyler Patchen

News Reporter

As­traZeneca’s ap­pli­ca­tion for a $360 mil­lion man­u­fac­tur­ing site in a Dublin sub­urb is yet to be ac­cept­ed, but it is mak­ing progress.

The fa­cil­i­ty, which …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times